The global Dravet Syndrome Market is poised to exhibit steady revenue growth, primarily driven by the increasing prevalence of epilepsy. According to the National Organization for Rare Disorders, approximately 0.0064% of Americans, or 1 in 15,700 individuals, are believed to be affected by Dravet syndrome. Of those, around 80-90% have both a SCN1A mutation and a clinical diagnosis of DS,...
English
العربية
Français
Español
Português
Deutsch
Türkçe
Nederlands
Italiano
Română
Português
Ελληνικά
Tiếng Việt